Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd > The timing is great but is it a fake out.

<< Previous

Bullboard Posts

Next >>

Comment by Nighttradeon Jul 10, 2020 8:44am

59 Views

Post# 31250237

RE:RE:The timing is great but is it a fake out.

I am willing to take the risk. It will be a 60% drop on the downside with a long hold, or a gain of 2x or more on the upside. I just bought in at the PP price, but understand why people who bought higher are angry.

<< Previous

Bullboard Posts

Next >>

Morning Market Outlook for Nov. 7, 2024